Ocular Therapeutix, Inc. (OCUL)
10.27
-0.06
(-0.58%)
USD |
NASDAQ |
Mar 06, 16:00
10.27
0.00 (0.00%)
After-Hours: 20:00
Ocular Therapeutix Cash from Investing (TTM) : -11.88M for Dec. 31, 2025
Cash from Investing (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (TTM) Benchmarks
| Regeneron Pharmaceuticals, Inc. | -629.10M |
| Abbott Laboratories | -2.422B |
| EyePoint Plc | 68.58M |
| Quince Therapeutics, Inc. | 26.02M |
| Ernexa Therapeutics, Inc. | -0.022M |